Market Overview

Benzinga's Top #PreMarket Losers

Share:
Related
Market Panic Has Created 'Compelling' Opportunities In Biotech
Piper Jaffray Goes Overweight Sarepta, Expects FDA To Accept Next Key Drug Filing
Sarepta's DMD Drug Eteplirsen Gains FDA Priority Review (Zacks)
Related HSOL
Wild Swings In Solar Short Interest
US Stock Futures Point To Lower Open Monday

Sarepta Therapeutics (NASDAQ: SRPT) dipped 48.69% to $18.76 in the pre-market session. Sarepta reported a non-GAAP net loss of $21.3 million, or $0.63 per share. Piper Jaffray downgraded the stock from Overweight to Underweight.

Hanwha SolarOne Co (NASDAQ: HSOL) shares dropped 14.43% to $4.33 in pre-market trading on Q3 results.

Hologic (NASDAQ: HOLX) shares fell 12.66% to $20.00 in the pre-market trading after the company issued downbeat outlook for fiscal 2014. Canaccord Genuity downgraded the stock from Buy to Hold.

JA Solar Holdings Co (NASDAQ: JASO) dipped 3.89% to $11.60. JA Solar's trailing-twelve-month ROE is -24.62%.

Posted-In: PreMarket LosersNews Movers & Shakers Pre-Market Outlook Markets

 

Related Articles (HOLX + HSOL)

View Comments and Join the Discussion!

Get Benzinga's Newsletters